[1]Heusch G.Treatment of myocardial ischemia/reperfusion injury by ischemic and pharmacological postconditioning.[J]. Comprehensive Physiol, 2015, 5:1123-1145. [2]Liu X, Yu Z,Huang X, et al. Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway[J]. Am J Transl Res, 2016, 8:5169-5186. [3]Li X, Yang J, Yang J, et al. RP105 protects against myocardial ischemia-reperfusion injury via suppressing TLR4 signaling pathways in rat model.[J]. Exp Mol Pathol, 2016, 100:281-286. [4]邢子禾, 张荣雪, 李杨,等. miRNA146b在多种疾病中的作用及其机制研究进展[J]. 江苏大学学报(医学版), 2018, 28:454-458. [5]张卫强, 王涛, 张志明,等. 大鼠心肌缺血再灌注损伤模型的改进与评判[J]. 中国实验动物学报, 2018, 26:311-316. [6]Yang XL,Yue RC, Zhang J,et al. Gastrin protects against myocardial ischemia/reperfusion injury via activation of RISK (reperfusion injury salvage kinase) and SAFE (survivor activating factor enhancement) pathways[J]. J Am Heart Assoc, 2018, 7:e005171.doi:10.1161/JAHA.116.005171. [7]Yanping D, Min Y, Feng X, et al. Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia/reperfusion injury in rats[J]. PLoS One, 2015, 10:e0135435.doi:10.1371/journal.pone.0135435. [8]刘冲, 杨伟俊, 陈文. miRNA在心肌缺血再灌注损伤中作用机制研究进展[J]. 药物生物技术, 2017, 24:163-166. [9]He X, Zheng Y, Liu S, et al. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway[J]. J Cell Physiol, 2018,233:2476-2488. [10]孟剑锋, 彭辉, 李亮,等. 参松养心胶囊治疗心肌损伤疗效及对CK-MB,cTnT水平的影响[J]. 中华中医药学刊, 2020, 38:237-240. [11]苏晓莉, 王选琦, 吴晓鹏,等. 微小RNA-302b在急性心肌梗死患者血清中的表达及临床意义[J]. 中国心血管杂志, 2019, 24:343-345. [12]何莹莹,李宏娟,刘亚姣. 鹿茸多肽对大鼠心肌缺血再灌注损伤的保护作用及对血清心肌肌钙蛋白T、乳酸脱氢酶和肌酸激酶同工酶水平的影响[J]. 新乡医学院学报,2020,37:210-214. [13]夏杰, 薛继阳, 葛捍伟,等. HMGB1/TLR4信号通路在大鼠心肌缺血再灌注损伤中的作用[J]. 中华麻醉学杂志, 2018, 38:1141-1145. [14]朱腾, 孙经武, 刘成霞,等. 藏红花酸预处理对大鼠MI/RI中Caspase-3、TNF-α、NF-κB表达的影响[J]. 中成药, 2016, 38:927-929. [15]杨晶, 张晓坚, 胡长平. 吴茱萸次碱通过抑制TLR4/NF-κB信号通路保护大鼠心肌缺血/再灌注损伤[J]. 中国药理学通报, 2017, 33:1707-1712. |